- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04455425
Acquired Syphlis by Non Sexual Contact
Descriptive Cohort of Acquired Syphlis by Non Sexual Contact
Syphilis is classically described as a sexually transmitted disease. As this source of contagious has been described long ago -mainly though by observation- when children presents with acquired syphilis, child abuse is always considered and must be ruled out by specialists in a careful evaluation.
However, muco-cutaneous lesions can be a contagious source for congenital syphilis; therefore the possibility of non-sexual transmission through intimate contact with infected people through humid lesions (such as in kisses, breastfeeding, food-handling) or contaminated fomites (towels, bed sheets, underwear, cups, pacifiers, cutlery) could be considered. Experts worldwide have observed this non-sexual transmission, as described in many reports in literature.
The investigators will study retrospectively patients from a cohort with non-sexual transmission. The diagnosis criteria used for acquired syphilis were as follows: age under 18 years with treponemic and nontreponemic positive tests, secondary-syphilis suspicious lesions and negative maternal syphilis serology. Nonsexual contagious was defined as contacts without physical and psychosocial indicators of sexual abuse according to current guides. In this cohort, in every case a psychosocial evaluation was completed with a written report in order to evaluate sexual contact probability.
The teamo will describe these patients clinical and laboratory findings, family and close acquaintances serologies and probable source of contagious.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Capital Federal
-
Buenos Aires, Capital Federal, Argentina, 1425
- Hospital de Niños Ricardo Gutierrez
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
INCLUSION CRITERIA:
- Children with treponemic and non-treponemic positive tests with primary or secondary-syphilis suspicious lesions
EXCLUSION CRITERIA:
- Children with diagnose criteria positive for Congenital syphilis
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Describe diagnose process of a cohort of children with assumed non-sexual acquired syphilis
Time Frame: Past 20 years
|
Describe the interdisciplinary approach of patients with acquired syphilis and how non-sexual transmission was assumed
|
Past 20 years
|
|
Describe serology titers from patients with non - sexually acquired syphilis and from their close contacts
Time Frame: Past 20 years
|
Investigators will report serology titers from patients with non - sexually acquired syphilis at diagnose and follow-up until cure, and from their close contacts at diagnose and during follow up of those resulting positive at contact screening
|
Past 20 years
|
|
Describe reported symptoms and physical findings at diagnose and during follow-up f children with assumed non-sexual acquired syphilis and their close contacts
Time Frame: Past 20 years
|
Investigators will describe symptoms and physical findings from patients with non - sexually acquired syphilis at diagnose and follow-up until cure, and from their close contacts at diagnose and during follow up of those resulting positive at contact screening
|
Past 20 years
|
Collaborators and Investigators
Investigators
- Principal Investigator: Guillermo Moscatelli, MD, Principal Investigator
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Si non sexual
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Syphilis Infection
-
Queen's Medical CenterNot yet recruitingSyphilis InfectionUnited States
-
Unity Health TorontoUniversity of TorontoRecruiting
-
bioLytical LaboratoriesSaint Vincent's Hospital MelbourneNot yet recruitingHepatitis B Infection | Syphilis Infection | HIV1 Infection | HIV 2 InfectionAustralia
-
MedMira Laboratories Inc.Public Health Agency of Canada (PHAC)CompletedSyphilis | Syphilis Infection | Early Syphilis, SymptomaticCanada
-
NOWDiagnostics, Inc.CompletedSyphilis Infection | Treponema Pallidum InfectionUnited States
-
bioLytical LaboratoriesEpicentreRecruitingHepatitis B Infection | HIV 1 Infection | Syphilis Infection | HIV 2 InfectionSouth Africa
-
Bangrak STIs CenterMahidol UniversityRecruitingChlamydia | Gonorrhea | Syphilis InfectionThailand
-
Makerere UniversityInfectious Diseases Institute, UgandaUnknown
-
University of WashingtonNational Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaboratorsCompletedHIV Infections | HIV/AIDS | Neisseria Gonorrheae Infection | Chlamydia Trachomatis Infection | Syphilis InfectionKenya
-
Unity Health TorontoWithdrawn